Male breast cancer added to list of obesity-associated cancers
the ONA take:
Obesity is set to overtake tobacco as the global leading cause of cancer, according to recent reports from the American Society of Clinical Oncology annual conference.
Research from the University of Leeds adds an increase in cases of male breast cancer to the growing list of cancers associated with rising obesity rates.
Fat cells contain enzymes that convert male hormones into female hormones. Therefore, men with higher levels of fat—body mass index higher than 25—have a higher levels of female hormones in their blood.
The researchers also observed cholesterol can be converted into a compound that mimics the activity of estrogen. Obese men tend to higher cholesterol levels, so they have more of estrogen-mimicking compound in their blood as well.
Researchers report that more than 90% of male breast cancers have cell surface receptors that recognize female hormones and use them to grow. The increased number of overweight and obese people is one of the most worrying global public health issues.
The researchers stress that obesity is a preventable condition and encourage men to take steps to reduce their risks of obesity-associated diseases, especially men with a family history of BRCA mutation.
An increase in cases of male breast cancer to the growing list of cancers associated with rising obesity rates.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|